S
Samir Haddad
Researcher at King Saud bin Abdulaziz University for Health Sciences
Publications - 50
Citations - 2499
Samir Haddad is an academic researcher from King Saud bin Abdulaziz University for Health Sciences. The author has contributed to research in topics: Intensive care unit & Traumatic brain injury. The author has an hindex of 21, co-authored 49 publications receiving 2228 citations. Previous affiliations of Samir Haddad include King Abdulaziz Medical City & Monash University.
Papers
More filters
Journal ArticleDOI
Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.
Yaseen M. Arabi,Ousama Dabbagh,Hani Tamim,Abdullah Al-Shimemeri,Ziad A. Memish,Samir Haddad,Sofia Syed,Hema R. Giridhar,Asgar H. Rishu,Mouhamad O. Al-Daker,Salim H. Kahoul,Riette J. Britts,Maram Sakkijha +12 more
TL;DR: Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia.
Journal ArticleDOI
Critical care management of severe traumatic brain injury in adults
Samir Haddad,Yaseen M. Arabi +1 more
TL;DR: The critical care management of severe TBI will be discussed with focus on monitoring, avoidance and minimization of secondary brain insults, and optimization of cerebral oxygenation and CPP.
Journal ArticleDOI
Early tracheostomy in intensive care trauma patients improves resource utilization: a cohort study and literature review
TL;DR: Early tracheostomy in trauma ICU patients is associated with shorter duration of mechanical ventilation and ICU LOS, without affecting ICU or hospital outcome.
Journal ArticleDOI
Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial
Alistair Nichol,Craig French,Lorraine Little,Samir Haddad,Jeffrey J. Presneill,Jeffrey J. Presneill,Jeffrey J. Presneill,Yaseen M. Arabi,Yaseen M. Arabi,Michael Bailey,D. James Cooper,Jacques Duranteau,Olivier Huet,Anne Mak,Colin McArthur,Colin McArthur,Ville Pettilä,Ville Pettilä,Markus B. Skrifvars,Shirley Vallance,Dinesh Varma,Judy Wills,Rinaldo Bellomo,Rinaldo Bellomo,Rinaldo Bellomo +24 more
TL;DR: Following moderate or severe traumatic brain injury, erythropoietin did not reduce the number of patients with severe neurological dysfunction (GOS-E level 1-4) or increase the incidence of deep venous thrombosis of the lower limbs.
Journal ArticleDOI
Mortality reduction after implementing a clinical practice guidelines–based management protocol for severe traumatic brain injury
Yaseen M. Arabi,Samir Haddad,Hani Tamim,Abdulaziz Al-Dawood,Abdulaziz Al-Dawood,Saad Al-Qahtani,Saad Al-Qahtani,Ahmad Ferayan,Ibrahim Al-Abdulmughni,Jalal Al-Oweis,Asia Rugaan +10 more
TL;DR: The protocol implementation was associated with a reduction in hospital and ICU mortality and an increase in the frequency of tracheostomies and in ICU or hospital LOS, suggesting that the improved survival was not associated with the increased number of surviving patients with severe disability and that the functional status might have also improved.